Back to CA Clearstead Advisors, LLC
MRNA
Showing 8 of 26 quarters
Position history for CAClearstead Advisors, LLC's holdings in Moderna, Inc.
Yes. Clearstead Advisors holds 2,351 shares of MRNA (Moderna), worth $452,870, as of its Q3 2026 13F filing. It increased the position by 1,445 shares (+159.5%) from Q2 2026. Clearstead Advisors has held MRNA since Q2 2020, across 26 quarterly 13F filings.
Current Value
$452,870
Current Shares
2,351
Total Value Change
+$448,213
Total Shares Change
+2,239
Quarter-by-Quarter History